Black Diamond Therapeutics (BDTX) Other financing activities (2019 - 2025)
Black Diamond Therapeutics (BDTX) posted Other financing activities of $32000.0 for Q1 2025, down 89.0% on a QoQ basis from $291000.0 in Q4 2024, and down 78.67% year-over-year from $150000.0 in Q1 2024.
Black Diamond Therapeutics (BDTX) Other financing activities (2019 - 2025) Analysis & Trends
Black Diamond Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $32000.0 for Q1 2025.
- Quarterly Other financing activities fell 78.67% year-over-year to $32000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $935000.0 (up 416.57% YoY) and the FY2024 annual result came in at $1.1 million, up 1184.15% from the prior year.
- Other financing activities was $32000.0 for Q1 2025 at Black Diamond Therapeutics, down from $291000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $481000.0 in Q1 2021 and bottomed at -$46000.0 in Q4 2023.
- A 5-year average of $148071.4 and a median of $113500.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 2906.25% in 2021, while the deepest fall reached 99.91% in 2021.
- Black Diamond Therapeutics' Other financing activities stood at $64000.0 in 2021, then sank by 143.75% to -$28000.0 in 2022, then tumbled by 64.29% to -$46000.0 in 2023, then soared by 732.61% to $291000.0 in 2024, then plunged by 89.0% to $32000.0 in 2025.
- Business Quant data shows BDTX's Other financing activities at $32000.0 in Q1 2025, $291000.0 in Q4 2024, and $248000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 291,000.00 |
| Dec 31, 2024 | 291,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |